StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)

Close on Nov 18, 2026Market cap $121.23MP/E –Yield –

NRX Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NRX Pharmaceuticals's pe ratio was 813.6× on Jan 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jan 31, 2020813.6×+6.9
2019Dec 31, 2019806.8×–

More NRX Pharmaceuticals figures

See a number that looks wrong?